API
< Back to situations

[ORGANIZATION]

Roche Italia

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [BR] [IT]

Risdiplam tablet availability for SMA treatment

2 clusters · 6 sources · last updated

Latest: Anvisa approves Evrysdi Go tablet for spinal muscular atrophy

The availability of a new tablet formulation of risdiplam for treating Spinal Muscular Atrophy (SMA) has expanded in different regions. In Italy, the tablet formulation was introduced to complement existing syrup solut

[QUIET] [HEALTH] [US] [IT] [GR]

FDA approves Rasonque; EMA recommends for pancreatic cancer

44 clusters · 321 sources · last updated

Latest: Pancreatic cancer: New research and treatment developments in Greece

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R